1131 - 1140 of 8587 Results
Title
Year
-
RESTRICTEDTitle: Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 13Issue #: 3Start Page: 635End Page: 646Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-016-0449-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-016-0449-z.pdfCitation Count: 17
-
RESTRICTEDTitle: Approach to Cognitive Impairment in Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1495End Page: 1510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00963-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00963-x.pdfCitation Count: 38
-
RESTRICTEDTitle: Emerging Targeted Therapeutics for Genetic Subtypes of ParkinsonismJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1378End Page: 1392Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00920-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00920-8.pdfCitation Count: 27
-
RESTRICTEDTitle: Nucleic Acid–Based Therapeutics for Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 16Issue #: 2Start Page: 287End Page: 298Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-019-00714-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-019-00714-7.pdfCitation Count: 45
-
RESTRICTEDTitle: Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and RetentionJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1724End Page: 1735Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00960-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00960-0.pdfCitation Count: 37
-
RESTRICTEDTitle: Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?Journal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1539End Page: 1562Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00940-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00940-4.pdfCitation Count: 23
- Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments2020RESTRICTEDTitle: Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical TreatmentsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1681End Page: 1693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00914-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00914-6.pdfCitation Count: 58
-
RESTRICTEDTitle: Manganism in the 21st century: The Hanninen lectureJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 45Issue #:Start Page: 201End Page: 207Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2013.09.007Best OA location URL: https://europepmc.org/articles/pmc3992192?pdf=renderCitation Count: 65
-
RESTRICTEDTitle: Cell therapy in Parkinson’s diseaseJournal Name: NeuroRXPublisher: Springer Science and Business Media LLCVol: 1Issue #: 4Start Page: 382End Page: 393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1602/neurorx.1.4.382Best OA location URL: https://link.springer.com/content/pdf/10.1602%2Fneurorx.1.4.382.pdfCitation Count: 334
-
RESTRICTEDTitle: Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson’s diseaseJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 103Issue #:Start Page: 305End Page: 315Publication Date:Open Access(OA) Status: RESTRICTEDLicense: elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.neubiorev.2019.05.016Best OA location URL: http://manuscript.elsevier.com/S0149763419300284/pdf/S0149763419300284.pdfCitation Count: 95